NICOLE MCCOLE: Open Payments
NPI 1427761550 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,578 in 77 payments from 27 companies in 2025. Trend: 2023 $1,064 · 2024 $1,393 · 2025 $1,578
Food & beverage: $1,578
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $226 |
| Daiichi Sankyo Inc. | 12 | $191 |
| AstraZeneca Pharmaceuticals LP | 9 | $174 |
| Novartis Pharmaceuticals Corporation | 6 | $117 |
| Eisai Inc. | 4 | $91 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $78 |
| Incyte Corporation | 3 | $69 |
| SOBI, INC | 3 | $68 |
| Genmab U.S., Inc. | 3 | $65 |
| PFIZER INC. | 2 | $52 |
Products named: TALVEY, Enhertu, DATROWAY, Lenvima, ERLEADA, MONJUVI, Doptelet, IMFINZI.
Industry payments across PA — which companies pay providers there.
